Voriconazole-Associated Cutaneous Malignancy: A Literature Review on Photocarcinogenesis in Organ Transplant Recipients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Voriconazole-Associated Cutaneous Malignancy: A Literature Review on Photocarcinogenesis in Organ Transplant Recipients
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 58, Issue 7, Pages 997-1002
Publisher
Oxford University Press (OUP)
Online
2013-12-22
DOI
10.1093/cid/cit940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients
- (2013) J.M. McLaughlin et al. Transplant Infectious Disease
- Duration of Voriconazole Exposure: An Independent Risk Factor for Skin Cancer After Lung Transplantation
- (2012) Fiona O. Zwald et al. DERMATOLOGIC SURGERY
- High frequency of voriconazole-related phototoxicity in cystic fibrosis patients
- (2012) S. Rondeau et al. EUROPEAN RESPIRATORY JOURNAL
- Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis
- (2012) Sophia L. Markantonis et al. Journal of Cystic Fibrosis
- High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients
- (2012) Jonathan P. Singer et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole
- (2012) Ashley Feist et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Skin cancer in solid organ transplant recipients: Advances in therapy and management
- (2011) Fiona O’Reilly Zwald et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phototoxicity and photocarcinogenesis associated with voriconazole
- (2011) O. Epaulard et al. MEDECINE ET MALADIES INFECTIEUSES
- Pharmacogenomics of the triazole antifungal agent voriconazole
- (2011) Gerd Mikus et al. PHARMACOGENOMICS
- Long-Term Voriconazole and Skin Cancer: Is There Cause for Concern?
- (2011) Cornelius J. Clancy et al. Current Infectious Disease Reports
- Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients
- (2010) Maud Berge et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients
- (2010) Aniket Vadnerkar et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients
- (2009) O. Epaulard et al. CLINICAL MICROBIOLOGY AND INFECTION
- Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole
- (2009) Edward W. Cowen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Aggressive Cutaneous Squamous Cell Carcinoma Associated with Prolonged Voriconazole Therapy in a Renal Transplant Patient
- (2008) A. Vanacker et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B
- (2008) Amparo Solé INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now